DÜSSELDORF, Germany, February 4 /PRNewswire/ --

- Sales up by 48% at EUR958 Million - EBITDA Margin Reaches High Level of 19%

- Another Acquisition in the Target Segment of Pharmaceutical Plastics in South America: Brazilian Market Leader for Pharma Plastic Taken Over

According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%; the adjusted Group EBITDA margin reached 19%. "This gratifying development completely and fully confirms our strategy," says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG: "With the help of acquisitions we have successfully expanded our global presence and set the course for further growth."

BORDEAUX-MÉRIGNAC, France, February 4 /PRNewswire/ --

- NAVIGATOR DVB-SH the First Such Equipment Available on the Market

VEENENDAAL, The Netherlands, February 4 /PRNewswire/ -- Nucletron BV and clinicians at The Cancer Centre, Northern Ireland, proudly report the first IMRT clinical treatment within the Conventional or Hypofractionated High-Dose Intensity Modulated Radiotherapy for Prostate Cancer (CHHiP) clinical trial utilizing Nucletron's Oncentra(R) MasterPlan. CHHiP, part of the NCRN/NCRI portfolio of cancer trials and sponsored by the Institute of Cancer Research, is a Phase III national, multi-centre, randomized trial for the treatment of prostate cancer using external beam radiotherapy.

DUSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%; the adjusted Group EBITDA margin reached 19%. "This gratifying development completely and fully confirms our strategy," says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG: "With the help of acquisitions we have successfully expanded our global presence and set the course for further growth."

Rapid expansion of operations in the South American pharma and life science market

NEW YORK, February 4 /PRNewswire/ --

EquiLend announced today that a new trading service, Trade2O, has been added to the firm's already robust trading platform. Trade2O automates the negotiation and agreement of trade terms for global Equities and Fixed Income securities, giving traders a rapid and simple way to process trades straight through to their proprietary systems.

Currently, EquiLend's AutoBorrow trading service is a hub for processing over 18,000 trades daily valuing more than $20 billion USD. Trade2O is gaining momentum internationally, reaching the Japanese market, the United States and major European markets.

About EquiLend

REDMOND, Washington, February 4 /PRNewswire/ --

- Sentencing signals the end of Taiwan-based operation, the largest known producer and distributor of fake Microsoft products in the world from 1997 to 2003.

Prison sentences handed down to counterfeiters by a Taipei, Taiwan, court mark the end of a string of successful prosecutions by international law enforcement agencies, bringing a global software counterfeiting ring to a final halt. Between 1997 and 2003, Huang Jer-sheng, owner of the Taipei-based distributor Maximus Technology Inc, and his associates were responsible for the production and distribution of more than 90 per cent of the high-quality counterfeit Microsoft software products either seized by law enforcement or test-purchased around the world.